TAKEDA PHARMACEUTICAL CO LTD - TAK
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Apr 28, 2026 | President and CEO | A | A | 78,978.0 | 0.0 | 0.0 | 125,345.0 | View | |
| Apr 28, 2026 | President and CEO | A | A | 165,370.0 | 0.0 | 0.0 | 418,803.0 | View | |
| Apr 28, 2026 | President and CEO | A | A | 78,900.0 | 0.0 | 0.0 | 1,014,200.0 | View | |
| Apr 28, 2026 | Chief Financial Officer | A | A | 7,814.0 | 0.0 | 0.0 | 16,619.0 | View | |
| Apr 28, 2026 | Chief Financial Officer | A | A | 7,800.0 | 0.0 | 0.0 | 57,900.0 | View | |
| Apr 28, 2026 | President, R&D | A | A | 212,470.0 | 0.0 | 0.0 | 806,572.0 | View | |
| Apr 28, 2026 | Chief Data & Tech. Officer | A | A | 34,994.0 | 0.0 | 0.0 | 159,126.0 | View | |
| Apr 28, 2026 | President, OBU | A | A | 64,988.0 | 0.0 | 0.0 | 258,136.0 | View | |
| Apr 28, 2026 | Chief Transformation Officer | A | A | 59,990.0 | 0.0 | 0.0 | 228,503.0 | View | |
| Apr 28, 2026 | CEO - Elect | A | A | 105,416.0 | 0.0 | 0.0 | 430,145.0 | View | |
| Apr 28, 2026 | President, IBU | A | A | 72,124.0 | 0.0 | 0.0 | 297,363.0 | View | |
| Apr 28, 2026 | Head, Strat. & Port. Dev. | A | A | 27,740.0 | 0.0 | 0.0 | 172,348.0 | View |